Search by Drug Name or NDC

    NDC 59779-0634-26 childrens multi symptom cold 5; 100; 2.5 mg/5mL; mg/5mL; mg/5mL Details

    childrens multi symptom cold 5; 100; 2.5 mg/5mL; mg/5mL; mg/5mL

    childrens multi symptom cold is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by CVS Pharmacy. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 59779-0634
    Product ID 59779-634_72efd514-5cb9-4b24-8ccd-58fcd34b0a80
    Associated GPIs 43997303100960
    GCN Sequence Number 066559
    GCN Sequence Number Description guaifen/dextromethorphan/PE LIQUID 5-2.5 MG/5 ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 28875
    HICL Sequence Number 000216
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PHENYLEPHRINE
    Brand/Generic Generic
    Proprietary Name childrens multi symptom cold
    Proprietary Name Suffix n/a
    Non-Proprietary Name dextromethorphan HBr, guaifenesin, phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 5; 100; 2.5
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name CVS Pharmacy
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 59779-0634-26 (59779063426)

    NDC Package Code 59779-634-26
    Billing NDC 59779063426
    Package 1 BOTTLE in 1 CARTON (59779-634-26) / 118 mL in 1 BOTTLE
    Marketing Start Date 2016-06-11
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 72efd514-5cb9-4b24-8ccd-58fcd34b0a80 Details

    Revised: 6/2016